Article
Author(s):
Top news of the week from Specialty Pharmacy Times.
5. What Pharmacists Should Know About Biologics, Biosimilars
The changing pharma landscape with biologic drugs and the emergence of biosimilars presents unique opportunities for pharmacists, but also raises new challenges as time goes on. Read more.
4. AbbVie Launches Multiple Myeloma Research Partnership
AbbVie recently announced the launch of a collaboration with the International Myeloma Foundation (IMF) to conduct a retrospective review to improve the understanding of multiple myeloma to inform new treatment option. Read more.
3. Model Helps Predict Mortality Risk for Breast Cancer Survivors, Payers
A study presented at the 11th European Breast Cancer Conference discussed a novel model that could be used to calculate the risk of death among breast cancer survivors. Read more.
2. Siponimod May Delay Disability Progression in Secondary Progressive Multiple Sclerosis
Novartis recently announced positive results from the phase 3 EXPAND clinical trial of siponimod in secondary progressive multiple sclerosis. Read more.
1. Key Trends in Home Infusion, Specialty for 2018
Several new and ongoing trends are expected to be of significant importance in the home infusion and specialty pharmacy space. Read more.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a